Hemoglobin red cell distribution width ratio as a prognostic marker in patients with locally advanced lung adenocarcinoma-Reference-Cited by-同舟云学术

Hemoglobin red cell distribution width ratio as a prognostic marker in patients with locally advanced lung adenocarcinoma

Published:2023-10-27 Issue:4 Volume:5 Page:329-333
ISSN:2718-0115
Container-title:Anatolian Current Medical Journal
language:
Short-container-title:

Author:

KURT Hasret Gizem¹^ORCID,ÖZTÜRK Ayperi²^ORCID,ÖZTÜRK ERGÜR Figen²^ORCID

Affiliation:

1. SAĞLIK BİLİMLERİ ÜNİVERSİTESİ, ANKARA ATATÜRK GÖĞÜS HASTALIKLARI VE GÖĞÜS CERRAHİSİ SAĞLIK UYGULAMA VE ARAŞTIRMA MERKEZİ

2. UNIVERSITY OF HEALTH SCIENCES, ANKARA ATATÜRK HEALTH RESEARCH CENTER FOR PULMONOLOGY AND THORACIC SURGERY

Abstract

Aims: Hemoglobin/red cell distribution width ratio (HRR) has been defined as an effective prognostic factor in various malignancies. The aim of this study is to investigate the prognostic role of HRR in locally advanced lung adenocarcinoma. Methods: 626 patients diagnosed with locally advanced lung adenocarcinoma were screened. The best cut-off point of HRR for overall survival (OS) and progression free survival (PFS) was determined by ROC analysis. A HRR cut-off value was determined, patients were classified as having lower or higher HRR. Both groups’ clinical, demographic, laboratory values were compared. To identify independent predictors of prognosis, multivariate cox regression analysis was used. Results: A total of119 patients were included. The best cut-off point of HRR in determining OS was 0.963%.HRR below the cut-off value increased mortality by 2.2fold.The group with HRR

Publisher

Anatolian Current Medical Journal

Subject

General Medicine

Reference20 articles.

1. Wang L, Wang C, Wu S, Li Y, Guo W, Liu M. Red blood cell distribution width is associated with mortality after acute ischemic stroke: a cohort study and systematic review. Ann Transl Med. 2020; 8(4):81.

2. Charlson ME, Pompei P, Ales KL, Mackenzie CR. A newmethod of classifying prognostic comorbidity in longitudinal studies: development and validation. J Chronic Dis. 1987;40:373-383.

3. Warwick R, Mediratta N, Shackcloth M, Shaw M, McShane J, Poullis M. Preoperative red cell distribution width in patients under going pulmonary resections for non-small-cell lung cancer. Eur J Cardiothorac Surg. 2014;45:108-113.

4. Shin NR, Lee YY, Kim SH, et al. Prognostic value of pretreatment haemoglobin level in patients with early cervical cancer. Obstet Gynecol Sci. 2014;57:28-36.

5. Riedl J, Posch F, Königsbrügge O, et al. Red cell distribution width and other red blood cell parameters in patients with cancer: association with risk of venous thromboembolism and mortality. PLoS ONE. 2014;9:e111440.